- Home
- ELF vs ROIV Comparison
ELF vs ROIV Comparison
Compare ELF & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELF | ROIV |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 14.1B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELF | ROIV |
|---|---|---|
| Price | $85.81 | $21.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $127.00 | $24.31 |
| AVG Volume (30 Days) | 1.6M | ★ 8.4M |
| Earning Date | 02-05-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $1,385,640,000.00 | $20,329,000.00 |
| Revenue This Year | $20.59 | N/A |
| Revenue Next Year | $16.79 | $741.42 |
| P/E Ratio | $58.71 | ★ N/A |
| Revenue Growth | ★ 13.80 | N/A |
| 52 Week Low | $49.40 | $8.73 |
| 52 Week High | $150.99 | $23.47 |
Technical Indicators
Market Signals| Indicator | ELF | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 53.52 |
| Support Level | $75.73 | $21.15 |
| Resistance Level | $80.87 | $22.14 |
| Average True Range (ATR) | 3.45 | 0.65 |
| MACD | 1.22 | -0.13 |
| Stochastic Oscillator | 82.61 | 52.76 |
Price Performance
Historical ComparisonAbout ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.